Please note that if you are under 18, you won't be able to access this site.
Are you 18 years old or above?
Upload
Import
My Account
Mode
Login
Register
VJHemOnc Podcast
|
Subscribers
Subscribe
0
Episodes
PlayLists
Liked episodes
About
Latest episodes
28:07
iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
VJHemOnc Podcast
1 Views
·
1 year ago
18:05
iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
VJHemOnc Podcast
0 Views
·
1 year ago
10:51
Applications of MRD in multiple myeloma: using MRD to guide treatment decisions
VJHemOnc Podcast
0 Views
·
1 year ago
16:52
The importance of addressing racial disparities & differences in survival in patients with acute leukemias
VJHemOnc Podcast
0 Views
·
1 year ago
10:05
Pre-MDS states: improving prognosis, novel therapeutic approaches, and challenges with distinguishing these conditions
VJHemOnc Podcast
0 Views
·
1 year ago
08:17
Accelerated-phase MPNs: mutational landscape, challenges, and novel treatment strategies being explored
VJHemOnc Podcast
0 Views
·
1 year ago
07:07
Determining the optimal sequencing of bispecifics and CAR-T cells in multiple myeloma
VJHemOnc Podcast
0 Views
·
1 year ago
11:27
Overcoming barriers to CAR-T therapy: improving access and cost
VJHemOnc Podcast
0 Views
·
1 year ago
06:14
The importance of addressing quality of life and improving symptom management in MPNs
VJHemOnc Podcast
0 Views
·
1 year ago
06:47
Hemophilia: the current standard of care and the value of novel gene therapies
VJHemOnc Podcast
0 Views
·
1 year ago
14:14
CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors
VJHemOnc Podcast
0 Views
·
1 year ago
08:24
Myeloma highlights at EHA 2023: CARTITUDE-4 & CARTITUDE-1 updates & the use of MRD in clinical practice
VJHemOnc Podcast
0 Views
·
1 year ago
16:48
Lymphoma highlights at EHA 2023: sequencing bispecifics & CAR-T cells, bridging therapy & toxicity management
VJHemOnc Podcast
0 Views
·
1 year ago
10:14
The importance of genomic testing in CLL and its role in clinical decision-making
VJHemOnc Podcast
0 Views
·
2 years ago
17:59
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
VJHemOnc Podcast
0 Views
·
2 years ago
11:35
Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more
VJHemOnc Podcast
0 Views
·
2 years ago
16:02
iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies
VJHemOnc Podcast
0 Views
·
2 years ago
11:22
iwNHL Session III: Exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
VJHemOnc Podcast
0 Views
·
2 years ago
15:43
Recent updates in CML: treatment strategies, clinical trials, and novel agents
VJHemOnc Podcast
0 Views
·
2 years ago
13:38
iwNHL Session II: Understanding and harnessing the immune microenvironment against lymphoma
VJHemOnc Podcast
0 Views
·
2 years ago
Show more
Home
Latest episodes
Trending
Top Episode
Popular Podcasts
Explore more
Help
Choose a payment method
Language
English
Arabic
Dutch
French
German
Russian
Spanish
Turkish
Hindi
Chinese
Urdu
Indonesian
Croatian
Hebrew
Bengali
Japanese
Portuguese
Italian
Persian
Swedish
Vietnamese
Danish
Filipino
Pay By Wallet
Log In
Username
Password
Forgot your password?
Remember this device
Login with
New here?
Register
Sign Up!
Username
E-mail address
Password
Must be at least 6 characters long.
Must contain a lowercase letter.
Must contain an uppercase letter.
Must contain a number or special character.
Confirm Password
Male
Female
By creating your account, you agree to our
Terms of use
&
Privacy Policy
Already have an account?
Log In